Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02492074

Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study

Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids on the Endocannabinoid System and Brain Function

Status
Withdrawn
Phase
Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Central Institute of Mental Health, Mannheim · Academic / Other
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The study evaluates the gene-environment interaction of the COMT-genotype on the effects of the phytocannabinoids delta-9-tetrahydrocannabinol, cannabidiol or a combination of both on induction of psychotic symptoms, endocannabinoid levels in human body fluids, neuronal processing, and neural oscillations. In addition the effects of the phytocannabinoids on lipid levels in serum and cerebrospinal fluid, cognition, neuronal processing assessed by fMRI as well as D2-receptor availability assessed by \[18F\] desmethoxyfallypride.

Conditions

Interventions

TypeNameDescription
DRUGDelta-9-tetrahydrocannabinoloral administration of delta-9-tetrahydrocannabinol
DRUGCannabidioloral administration of cannabidiol
DRUGPlacebooral administration of placebo

Timeline

Start date
2024-12-01
Primary completion
2025-04-01
Completion
2025-05-01
First posted
2015-07-08
Last updated
2025-03-13

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02492074. Inclusion in this directory is not an endorsement.